![Paul Glyer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Glyer
Founder at IOI Partners LLC
Paul Glyer active positions
Companies | Position | Start | End |
---|---|---|---|
Vennfi, Inc.
![]() Vennfi, Inc. Packaged SoftwareTechnology Services Vennfi, Inc. is a charity organization that simplifies the complex financial product of philanthropy, making it more accessible to donors of all sizes. The organization is headquartered in GA and partners with a venture-backed software company, Vennfi Charityvest, a sponsor of modern donor-advised funds, has facilitated nearly $100 million in total giving across thousands of donors. The American company offers a tax-smart giving account to donate cash, stock, and crypto to favorite charities and manage charitable giving with purpose. The company was founded by Koon David Jon, Paul Ashby Foltz, James Stephen Kump, and James Stephen Kump has been the CEO since incorporation. | Director/Board Member | 31/07/2017 | - |
IOI Partners LLC
![]() IOI Partners LLC Miscellaneous Commercial ServicesCommercial Services IOI Partners LLC provides business advisory services. The company is based in Zionsville, IN. The company was founded by Scott Atkin, Paul Glyer. | Consultant / Advisor | 31/12/2013 | - |
Founder | 31/12/2013 | - | |
Water Street Healthcare Partners LLC
![]() Water Street Healthcare Partners LLC Investment ManagersFinance Water Street Healthcare Partners LLC (Water Street Healthcare Partners) is a private equity firm founded in 2005. The firm is headquartered in Chicago, Illinois. | Consultant / Advisor | 30/11/2012 | - |
1 For 2 Education Foundation | Director/Board Member | 31/12/2013 | - |
Kolstrand, LLC | President | 31/03/2008 | - |
Axalbion Therapeutics Ltd.
![]() Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Axalbion Therapeutics Ltd. has developed a drug candidate for several therapeutic applications. The private company is based in Wythenshawe, UK. The British company has evaluated new patented TRPM8 agonists, which are molecular transducers expressed in sensory neurons. The TRPM8 ion channel is expressed by approximately 10-15% of somatosensory neurons. Axalbion Therapeutics focuses on treating dry eye syndrome (DES), which is a disorder of the tear film due to tear deficiency. The company was founded in 2021, and the CEO is Michael M. Kitt. | Director/Board Member | - | - |
Career history of Paul Glyer
Former positions of Paul Glyer
Companies | Position | Start | End |
---|---|---|---|
Beckman Coulter, Inc.
![]() Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Corporate Officer/Principal | 31/12/1997 | 31/12/2010 |
Treasurer | 31/12/1988 | 31/12/1997 |
Training of Paul Glyer
Peter F Drucker & Masatoshi Ito Graduate School of Management | Masters Business Admin |
The California State University | Undergraduate Degree |
Statistics
International
United States | 9 |
United Kingdom | 2 |
Operational
Director/Board Member | 3 |
Consultant / Advisor | 2 |
Founder | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 7 |
---|---|
Vennfi, Inc.
![]() Vennfi, Inc. Packaged SoftwareTechnology Services Vennfi, Inc. is a charity organization that simplifies the complex financial product of philanthropy, making it more accessible to donors of all sizes. The organization is headquartered in GA and partners with a venture-backed software company, Vennfi Charityvest, a sponsor of modern donor-advised funds, has facilitated nearly $100 million in total giving across thousands of donors. The American company offers a tax-smart giving account to donate cash, stock, and crypto to favorite charities and manage charitable giving with purpose. The company was founded by Koon David Jon, Paul Ashby Foltz, James Stephen Kump, and James Stephen Kump has been the CEO since incorporation. | Technology Services |
IOI Partners LLC
![]() IOI Partners LLC Miscellaneous Commercial ServicesCommercial Services IOI Partners LLC provides business advisory services. The company is based in Zionsville, IN. The company was founded by Scott Atkin, Paul Glyer. | Commercial Services |
Water Street Healthcare Partners LLC
![]() Water Street Healthcare Partners LLC Investment ManagersFinance Water Street Healthcare Partners LLC (Water Street Healthcare Partners) is a private equity firm founded in 2005. The firm is headquartered in Chicago, Illinois. | Finance |
1 For 2 Education Foundation | |
Kolstrand, LLC | |
Beckman Coulter, Inc.
![]() Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Health Technology |
Axalbion Therapeutics Ltd.
![]() Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Axalbion Therapeutics Ltd. has developed a drug candidate for several therapeutic applications. The private company is based in Wythenshawe, UK. The British company has evaluated new patented TRPM8 agonists, which are molecular transducers expressed in sensory neurons. The TRPM8 ion channel is expressed by approximately 10-15% of somatosensory neurons. Axalbion Therapeutics focuses on treating dry eye syndrome (DES), which is a disorder of the tear film due to tear deficiency. The company was founded in 2021, and the CEO is Michael M. Kitt. | Health Technology |
- Stock Market
- Insiders
- Paul Glyer
- Experience